Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Licenses Enhanced Version of ProSight PTM Proteomics Software

ORLANDO, Fla., Feb. 28 (GenomeWeb News) - Thermo Electron has licensed a new commercial version of ProSight PTM, a software developed by the University of Illinois for identifying and characterizing intact proteins and their post-translational modifications, GenomeWeb News has learned.


The software will be released in about six months, according to the software's lead developer, Neil Kelleher, who gave a presentation on ProSight PTM yesterday at the PITTCON conference. Kelleher is an assistant professor of chemistry at the Universityof Illinoisat Urbana-Champaign. GenomeWeb News spoke with Kelleher at the PITTCON meeting, held here this week.


A non-commercial version of ProSight PTM software is currently available for free here. The commercial version will differ from the non-commercial version in the way it performs batch processing, said Kelleher.


In addition, the commercial version of ProSight PTM will include a new method of searching referred to as the biomarker search mode. In this mode, the software specifically searches for protein fragments found in blood and tries to match them with top-down mass-spectrometry data.


"The commercial grade will be a lot more robust in terms of speed and features," Kelleher said.


A representative of Thermo Electron said the company prefers not reveal details about the licensing agreement and costs for ProSight PTM until a later date.


The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.